US2008004219A1PendingUtilityA1
Method for treating smooth muscle disorders with a neurotoxic component of a botulinum toxin
Est. expiryDec 28, 2013(expired)· nominal 20-yr term from priority
A61P 25/00A61P 29/00A61P 21/02A61P 19/02A61P 21/00A61K 38/4893A61K 39/08Y02A50/30
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Claims
exact text as granted — not AI-modified1 . (canceled)
6 . A method for treating a smooth muscle disorder, said method comprising administering to the patient a therapeutically effective amount of a neurotoxic component of a botulinum toxin in order to treat a smooth muscle disorder.
14 . A method for relieving a muscle spasm said method comprising administering to a patient a therapeutically effective amount of a neurotoxic component of a botulinum toxin.
21 - 22 . (canceled)
23 . The method of claim 6 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
24 . The method of claim 23 , wherein the botulinum toxin is a botulinum toxin type A.
25 . The method of claim 14 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
26 . The method of claim 25 , wherein the botulinum toxin is a botulinum toxin type A.
27 - 30 . (canceled)Join the waitlist — get patent alerts
Track US2008004219A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.